SCHEMBL3480853

SCHEMBL3480853

Cc1ccc(-n2ccc(C(F)(F)F)n2)cc1SCC(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.43
MAPT P10636 4/20 0.43
RAB9A P51151 4/20 0.38
PRMT6 Q96LA8 1/20 0.38
POLB P06746 1/20 0.37
NPSR1 Q6W5P4 3/20 0.37
HTT P42858 1/20 0.37
PAX8 Q06710 1/20 0.37
IDH1 O75874 3/20 0.34
IDH2 P48735 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
MMP12 P39900 1/20 0.33
SCN9A Q15858 1/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
F10 P00742 1/20 0.31
CTSS P25774 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3480930 0.86 NPC1 (0.42) NPC1MAPTRAB9APRMT6POLB
SCHEMBL3480517 0.82 NPC1 (0.37) NPC1MAPTRAB9APRMT6POLB
SCHEMBL3480582 0.82 NPC1 (0.43) NPC1MAPTRAB9ANPSR1HTT
SCHEMBL3480801 0.81 NPC1 (0.36) NPC1MAPTRAB9APRMT6POLB
SCHEMBL3480908 0.81 NPC1 (0.39) NPC1MAPTRAB9APRMT6POLB
SCHEMBL13217479 0.81 PRMT6 (0.37) NPC1MAPTRAB9APRMT6POLB
SCHEMBL16202042 0.80 MAPT (0.52) NPC1MAPTRAB9APRMT6POLB
SCHEMBL12880279 0.74
SCHEMBL6358778 0.72 NPC1 (0.44) NPC1MAPTRAB9APRMT6POLB
SCHEMBL3480443 0.72 NPC1 (0.41) NPC1MAPTRAB9APRMT6POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7767626-B2 3-arylphenyl sulfide derivative and insecticide and miticide KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2010-08-03 US disclosed
US-7612105-B2 3-arylphenyl sulfide derivative and insecticide and miticide KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2009-11-03 US disclosed
US-20090170883-A1 3-ARYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE AND MITICIDE KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2009-07-02 US disclosed
EP-1076053-B1 3-ARYLPHENYL SULFIDE DERIVATIVES AND INSECTICIDES AND MITICIDES KUMIAI CHEMICAL INDUSTRY CO (JP) 2006-11-29 EP disclosed
US-7037930-B2 3-arylphenyl sulfide derivative and insecticide and miticide KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2006-05-02 US disclosed
US-20050171097-A1 3-Arylphenyl sulfide derivative and insecticide and miticide KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2005-08-04 US disclosed
US-6858639-B2 3-Arylphenyl sulfide derivative and insecticide and miticide KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2005-02-22 US disclosed
US-20030069242-A1 3-arylphenyl sulfide derivative and insecticide and miticide KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2003-04-10 US disclosed
EP-1076053-A1 3-ARYLPHENYL SULFIDE DERIVATIVES AND INSECTICIDES AND MITICIDES KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2001-02-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170883-A1 3-ARYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE AND MITICIDE CBR3, MSRB3, CYP1B1 NPC1 2264/4885MAPT 4460/4885RAB9A 1903/4885
US-20030069242-A1 3-arylphenyl sulfide derivative and insecticide and miticide CYP1B1, CYP2B6, CBR3 NPC1 1795/4885MAPT 4619/4885RAB9A 1540/4885
US-20050171097-A1 3-Arylphenyl sulfide derivative and insecticide and miticide CBR3, MSRB3, CYP1B1 NPC1 2264/4885MAPT 4460/4885RAB9A 1903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.